Medpace
MEDP
MEDP
231 hedge funds and large institutions have $1.64B invested in Medpace in 2019 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 83 increasing their positions, 74 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
231
Holders Change
+15
Holders Change %
+6.94%
% of All Funds
5.01%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
58
Increased
83
Reduced
74
Closed
42
Calls
$10.4M
Puts
$10.3M
Net Calls
+$15K
Net Calls Change
-$1.88M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17.1M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$12.4M |
| 4 |
Capital Fund Management (CFM)
Paris,
France
|
+$11.8M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$11.3M |
Top Sellers
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$27.8M |
| 2 |
Bank of New York Mellon
New York
|
-$19.6M |
| 3 |
Two Sigma Advisers
New York
|
-$14.6M |
| 4 |
Renaissance Technologies
New York
|
-$14.5M |
| 5 |
Millennium Management
New York
|
-$14M |
